QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Correction An erratum has been published Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Waldo, G. L. Articles by Harden, T. K. Search for Related Content PubMed PubMed Citation Articles by Waldo, G. L. Articles by Harden, T. K.

Agonist Binding and Gq-Stimulating Activities of the Purified Human P2Y₁ Receptor

Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina

The human P2Y₁ receptor (P2Y₁-R) was purified after high-level expression from a recombinant baculovirus in Sf9 insect cells. Quantification by protein staining and with a radioligand binding assay using the high-affinity P2Y₁-R antagonist [³H]MRS2279 ([³H]2-chloro-N⁶-methyl-(N)-methanocarba-2'-deoxyadenosine 3',5'-bis-phosphate) indicated a nearly homogenous preparation of receptor protein. K_i values determined in [³H]MRS2279 binding assays for antagonists with the purified P2Y₁-R were in good agreement with the K_i and K_B values determined for these molecules in membrane binding and activity assays, respectively. Availability of P2Y₁-R in purified form allowed direct determination of nucleotide agonist affinities under conditions not compromised by nucleotide metabolism/interconversion, and an order of affinities of 2-methylthio-ADP (2MeSADP) > ADP = 2-methylthioATP = adenosine-5'-O-(3-thio)triphosphate = adenosine-5'-O(2-thiodiphosphate) >> ATP was obtained. The signaling activity of the purified P2Y₁-R was quantified after reconstitution in proteoliposomes with heterotrimeric G proteins. Steady-state GTP hydrolysis in vesicles reconstituted with P2Y₁-R and G_q12 was stimulated by the addition of either 2MeADP or RGS4 alone and was increased by up to 50-fold in their combined presence. EC₅₀ values of agonists for activation of the purified P2Y₁-R were similar to their respective K_i values determined in radioligand binding experiments with the purified receptor. Moreover, ATP exhibited 20-fold higher EC₅₀ and K_i values than did ADP and was a partial agonist relative to ADP and 2MeSADP under conditions in which no metabolism of the nucleotide occurred. Both RGS4 and PLC-1 were potent and efficacious GTPase-activating proteins for G_q and G₁₁ in P2Y₁-R–containing vesicles. These results illustrate that the binding and signaling properties of the human P2Y₁-R can be studied with purified proteins under conditions that circumvent the complications that occur in vivo.

Received September 3, 2003; accepted November 5, 2003.

Address correspondence to: Dr. T. Kendall Harden, Department of Pharmacology, CB#7365, University of North Carolina, Chapel Hill, Chapel Hill, NC 27599-7365. E-mail: tkh{at}med.unc.edu

This article has been cited by other articles:

				I. Milenkovic, I. Rinke, M. Witte, B. Dietz, and R. Rubsamen P2 Receptor-Mediated Signaling in Spherical Bushy Cells of the Mammalian Cochlear Nucleus J Neurophysiol, September 1, 2009; 102(3): 1821 - 1833. [Abstract] [Full Text] [PDF]

				J. E. Purvis, M. S. Chatterjee, L. F. Brass, and S. L. Diamond A molecular signaling model of platelet phosphoinositide and calcium regulation during homeostasis and P2Y1 activation Blood, November 15, 2008; 112(10): 4069 - 4079. [Abstract] [Full Text] [PDF]

				S. J. Rayment, V. Ralevic, D. A. Barrett, R. Cordell, and S. P. H. Alexander A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release FASEB J, February 1, 2007; 21(2): 577 - 585. [Abstract] [Full Text] [PDF]

				M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al. International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy Pharmacol. Rev., September 1, 2006; 58(3): 281 - 341. [Abstract] [Full Text] [PDF]

				C. Alvarado-Castillo, T. K. Harden, and J. L. Boyer Regulation of P2Y1 Receptor-Mediated Signaling by the Ectonucleoside Triphosphate Diphosphohydrolase Isozymes NTPDase1 and NTPDase2 Mol. Pharmacol., January 1, 2005; 67(1): 114 - 122. [Abstract] [Full Text] [PDF]

				M. Chhatriwala, R. G. Ravi, R. I. Patel, J. L. Boyer, K. A. Jacobson, and T. K. Harden Induction of Novel Agonist Selectivity for the ADP-Activated P2Y1 Receptor Versus the ADP-Activated P2Y12 and P2Y13 Receptors by Conformational Constraint of an ADP Analog J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1038 - 1043. [Abstract] [Full Text] [PDF]

				A. K. Filippov, J. M. Fernandez-Fernandez, S. J. Marsh, J. Simon, E. A. Barnard, and D. A. Brown Activation and Inhibition of Neuronal G Protein-Gated Inwardly Rectifying K+ Channels by P2Y Nucleotide Receptors Mol. Pharmacol., September 1, 2004; 66(3): 468 - 477. [Abstract] [Full Text] [PDF]